Open AccessA 4‐Site, Single‐Visit Intradermal Postexposure Prophylaxis Regimen for Previously Vaccinated Patients: Experiences with >5000 Patients
Author(s) -
Prapimporn Chattranukulchai Shantavasinkul,
Terapong Tantawichien,
Wipaporn Jaijaroensup,
Samran Lertjarutorn,
Ampai Banjongkasaena,
Henry Wilde,
Visith Sitprija
Publication year - 2010
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/656585
Subject(s) - medicine , regimen , booster (rocketry) , rabies , vaccination , immunogenicity , booster dose , virology , pediatrics , immunology , immunization , surgery , antibody , physics , astronomy
We previously demonstrated that 4‐site, intradermal, single‐visit rabies booster vaccination provides immunogenicity greater than that provided by the standard 2‐booster, 2‐visit regimen. The regimen has been routinely used in 5116 patients since 1998 without any treatment failure. It is not only effective but also saves vaccine costs and transportation expenses and improves compliance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom